- Report
- June 2025
- 400 Pages
Global
From €4331EUR$4,949USD£3,765GBP
- Report
- June 2025
- 400 Pages
Global
From €4331EUR$4,949USD£3,765GBP
- Report
- June 2025
- 400 Pages
Global
From €4331EUR$4,949USD£3,765GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2441EUR$2,789USD£2,122GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2441EUR$2,789USD£2,122GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2441EUR$2,789USD£2,122GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2441EUR$2,789USD£2,122GBP
- Report
- June 2025
- 200 Pages
Global
From €2441EUR$2,789USD£2,122GBP
- Report
- June 2025
- 200 Pages
Global
From €2441EUR$2,789USD£2,122GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2441EUR$2,789USD£2,122GBP
- Report
- June 2025
- 200 Pages
Global
From €2441EUR$2,789USD£2,122GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2441EUR$2,789USD£2,122GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2441EUR$2,789USD£2,122GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2441EUR$2,789USD£2,122GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2441EUR$2,789USD£2,122GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1750EUR$2,000USD£1,522GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1313EUR$1,500USD£1,141GBP
- Report
- August 2025
- 152 Pages
Global
From €3457EUR$3,950USD£3,005GBP
- Report
- August 2025
- 152 Pages
Global
From €3457EUR$3,950USD£3,005GBP
- Report
- February 2025
- 233 Pages
Global
From €2188EUR$2,500USD£1,902GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more